Volume 28, Issue 6 pp. 475-478

Selecting outcome parameters in studies aimed at improving rational use of antibiotics – practical considerations

S. Natsch Pharm D

S. Natsch Pharm D

Departments of Clinical Pharmacy

Search for more papers by this author
B. J. Kullberg MD

B. J. Kullberg MD

Internal Medicine, University Medical Center Nijmegen, Nijmegen, The Netherlands

Search for more papers by this author
Y. A. Hekster Pharm D

Y. A. Hekster Pharm D

Departments of Clinical Pharmacy

Search for more papers by this author
J. W. M. van der Meer MD

J. W. M. van der Meer MD

Internal Medicine, University Medical Center Nijmegen, Nijmegen, The Netherlands

Search for more papers by this author
First published: 03 December 2003
Citations: 4
Dr Stephanie Natsch, Department of Clinical Pharmacy, University Medical Center Nijmegen, PO Box 9101, 6500 HB Nijmegen, The Netherlands. Tel.: +31 24 361 6405; fax: +31 24 354 0331; e-mail: [email protected]

Summary

When designing studies of the optimal use of antimicrobial drugs, it is important to define at an early stage, which outcome parameters to use. It must be clear to which category a parameter to be measured belongs: the structure, the process or a clinical outcome. Attention must be paid to the measurement scales as well as the statistical tests to be used. The outcome measure must be sensitive, specific and reliable. Furthermore, the timeframe chosen for the performance of a study should be validated. Whether process parameters or clinical outcomes are to be preferred depends on the settings and the intended purpose. The essential point is the appropriate choice of outcome measure for the study. Examples drawn from the field of quality of use of antimicrobial drugs are discussed.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.